...
首页> 外文期刊>Medical care >The impact of medicare part D on medication adherence among older adults enrolled in medicare-advantage products
【24h】

The impact of medicare part D on medication adherence among older adults enrolled in medicare-advantage products

机译:医疗保险D部分对参加医疗保险优势产品的老年人的药物依从性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Little is known about how Medicare Part D affects the medication refill adherence for cardiovascular and diabetes medications, particularly among beneficiaries without prior drug coverage. OBJECTIVES: To evaluate Medicare Part D's effect on medication adherence among beneficiaries with hyperlipidemia, hypertension, and/or diabetes enrolled in Medicare Advantage products. RESEARCH DESIGN: We used a quasi-experimental pre-post design, with 3 treatment groups and a comparison group, to assess the effect of Part D on several measures of adherence to prescription medications. SUBJECTS: Adults aged 65 or older with hyperlipidemia, hypertension, and/or diabetes in 2003 continuously enrolled between 2004 and 2007 in a large Pennsylvania insurer's Medicare Advantage products. MEASURES: Medication possession ratios (MPR), good adherence with MPR >0.8, and intensity of treatment measured by average daily counts of pills per day of treatment. RESULTS: Part D improved MPRs in the group without prior drug coverage by 13.4 percentage points (95% CI, 10.1-16.8), 17.9 (95% CI, 13.7-22.1), and 13.5 (95% CI, 11.5-15.5) for those with hyperlipidemia, diabetes, and hypertension, respectively. Adherence improved less in the other 2 groups with limited prior drug benefits. Although the proportion of beneficiaries in the intervention groups who attained good adherence levels increased after Part D, less than 50%, 68%, and 78% of beneficiaries with hyperlipidemia, diabetes, and hypertension, respectively, attained good adherence. CONCLUSION: Part D increased adherence to medications that reduce the risk of cardiovascular events for patients with hypertension, diabetes, and hyperlipidemia. This should improve the health of the elderly people in the long run.
机译:背景:关于Medicare D部分如何影响心血管和糖尿病药物对药物补充的依从性知之甚少,特别是在没有事先药物覆盖的受益人中。目的:评估参加Medicare Advantage产品的高脂血症,高血压和/或糖尿病患者的Medicare Part D对药物依从性的影响。研究设计:我们采用准实验的前后期设计,包括3个治疗组和一个比较组,以评估D部分对几种处方药依从性的影响。对象:2003年,患有高脂血症,高血压和/或糖尿病的65岁或以上的成年人在2004年至2007年期间连续注册了宾夕法尼亚州一家大型保险公司的Medicare Advantage产品。措施:药物拥有率(MPR),MPR> 0.8的良好依从性和治疗强度(通过每天治疗的每日平均药丸数来衡量)。结果:在无先前药物覆盖的情况下,D部分的MPR改善了13.4个百分点(95%CI,10.1-16.8),17.9(95%CI,13.7-22.1)和13.5(95%CI,11.5-15.5)分别患有高脂血症,糖尿病和高血压的人。在其他两组中,既往药物获益有限,依从性改善较少。尽管干预组中达到良好依从性水平的受益者比例在D部分后有所增加,但分别只有不到50%,68%和78%的高脂血症,糖尿病和高血压受益者获得了良好依从性。结论:D部分增加了对药物的依从性,从而降低了高血压,糖尿病和高脂血症患者发生心血管事件的风险。从长远来看,这将改善老年人的健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号